美国FDA 指导原则 公开提供咨询委员会成员的财务利益信息和豁免最终指导(方便打印) 英文原版.pdfVIP

Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers FINAL GUIDANCE Comments and suggestions may be submitted at any time for agency consideration to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that is published in the Federal Register . F